These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 26034617)

  • 21. Validation and application of the Arabic version of the M. D. Anderson symptom inventory in Moroccan patients with cancer.
    Nejmi M; Wang XS; Mendoza TR; Gning I; Cleeland CS
    J Pain Symptom Manage; 2010 Jul; 40(1):75-86. PubMed ID: 20619213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Psychometric Evaluation of the Chinese Version of the M.D. Anderson Symptom Inventory-Heart Failure in Chinese Cancer Patients With Concurrent Heart Failure.
    Chair SY; Wang Q; Yu M; Kwok Wei So W; Tian C; Wing Hung Sit J; Mi Ling Wong E; Wing Han Chan C; Fadol A
    Rehabil Nurs; 2017; 42(6):354-361. PubMed ID: 29244037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the Amharic Version of the M. D. Anderson Symptom Inventory and Assessment of Symptoms in Ethiopian Cancer Patients.
    Anshabo AT; Migbaru S; Mulu A; Negusu D; Asfaw AA; Awoke D; Tigeneh W; Engidawork E
    J Pain Symptom Manage; 2016 May; 51(5):947-53. PubMed ID: 26988847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients.
    Armstrong TS; Vera-Bolanos E; Gning I; Acquaye A; Gilbert MR; Cleeland C; Mendoza T
    Cancer; 2011 Jul; 117(14):3222-8. PubMed ID: 21264841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom Inventory.
    Tseng TH; Cleeland CS; Wang XS; Lin CC
    Cancer Nurs; 2008; 31(3):E9-16. PubMed ID: 18453871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Symptom burden of cancer patients: validation of the German M. D. Anderson Symptom Inventory: a cross-sectional multicenter study.
    Schmidt H; Cleeland CS; Bauer A; Landenberger M; Jahn P
    J Pain Symptom Manage; 2015 Jan; 49(1):117-25. PubMed ID: 24858739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement properties of a patient-reported outcome measure assessing psoriasis severity: The psoriasis symptoms and signs diary.
    Mathias SD; Feldman SR; Crosby RD; Colwell HH; McQuarrie K; Han C
    J Dermatolog Treat; 2016 Aug; 27(4):322-7. PubMed ID: 26634943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psychometric Evaluation of a New Patient-Reported Outcome (PRO) Symptom Diary for Varicose Veins: VVSymQ(®) Instrument.
    Wright DD; Paty J; Turner-Bowker DM; Bradbury A
    Patient; 2016 Aug; 9(4):335-48. PubMed ID: 27016239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patients.
    Lin CC; Chang AP; Cleeland CS; Mendoza TR; Wang XS
    J Pain Symptom Manage; 2007 Feb; 33(2):180-8. PubMed ID: 17280923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Linguistic Validation of the M. D. Anderson Symptom Inventory in Persian-Speaking Iranian Cancer Patients.
    Saadatpour L; Hemati S; Habibi F; Behzadi E; Hashemi-Jazi MS; Kheirabadi G; Mirbagher L; Gholamrezaei A
    J Pain Symptom Manage; 2015 Sep; 50(3):387-393.e1. PubMed ID: 25980966
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Symptom recovery after thoracic surgery: Measuring patient-reported outcomes with the MD Anderson Symptom Inventory.
    Fagundes CP; Shi Q; Vaporciyan AA; Rice DC; Popat KU; Cleeland CS; Wang XS
    J Thorac Cardiovasc Surg; 2015 Sep; 150(3):613-9.e2. PubMed ID: 26088408
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.
    Rogers JL; Vera E; Acquaye A; Briceno N; Jammula V; King AL; Leeper H; Quezado MM; Gonzalez Alarcon J; Boris L; Burton E; Celiku O; Choi A; Christ A; Crandon S; Grajkowska E; Leggiero N; Lollo N; Penas-Prado M; Reyes J; Siegel C; Theeler BJ; Timmer M; Wall K; Wu J; Aldape K; Gilbert MR; Armstrong TS
    Neurooncol Pract; 2021 Aug; 8(4):460-474. PubMed ID: 34277024
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of different recall periods for the US National Cancer Institute's PRO-CTCAE.
    Mendoza TR; Dueck AC; Bennett AV; Mitchell SA; Reeve BB; Atkinson TM; Li Y; Castro KM; Denicoff A; Rogak LJ; Piekarz RL; Cleeland CS; Sloan JA; Schrag D; Basch E
    Clin Trials; 2017 Jun; 14(3):255-263. PubMed ID: 28545337
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Psoriasis Symptom Diary: development and content validity of a novel patient-reported outcome instrument.
    Lebwohl M; Swensen AR; Nyirady J; Kim E; Gwaltney CJ; Strober BE
    Int J Dermatol; 2014 Jun; 53(6):714-22. PubMed ID: 23557000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire.
    Coyne KS; Soliman AM; Margolis MK; Thompson CL; Chwalisz K
    Curr Med Res Opin; 2017 Feb; 33(2):193-200. PubMed ID: 27733082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The psychometric properties of cancer multisymptom assessment instruments: a clinical review.
    Aktas A; Walsh D; Kirkova J
    Support Care Cancer; 2015 Jul; 23(7):2189-202. PubMed ID: 25894883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
    Rosenthal DI; Mendoza TR; Chambers MS; Asper JA; Gning I; Kies MS; Weber RS; Lewin JS; Garden AS; Ang KK; S Wang X; Cleeland CS
    Head Neck; 2007 Oct; 29(10):923-31. PubMed ID: 17358040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What symptoms are important to patients? Developing a symptom burden measure for women with breast cancer.
    Whisenant MS; Strunk FA; Tripathy D; Williams LA
    Support Care Cancer; 2019 Dec; 27(12):4639-4647. PubMed ID: 30937601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.